Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EYES

Second Sight Medical Products (EYES) Stock Price, News & Analysis

Second Sight Medical Products logo

About Second Sight Medical Products Stock (NASDAQ:EYES)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$4.11
$13.05
52-Week Range
N/A
Volume
36,800 shs
Average Volume
132,982 shs
Market Capitalization
$54.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EYES Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Second Sight Medical Products and its competitors with MarketBeat's FREE daily newsletter.

EYES Stock News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
Q3 2024 GeneDx Holdings Corp Earnings Call
See More Headlines

EYES Stock Analysis - Frequently Asked Questions

Second Sight Medical Products, Inc. (NASDAQ:EYES) released its earnings results on Monday, June, 29th. The medical device company reported ($1.71) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.23) by $0.48.

Shares of Second Sight Medical Products reverse split before market open on Friday, August 19th 2022.The 1-3 reverse split was announced on Friday, August 19th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

Second Sight Medical Products (EYES) raised $32 million in an initial public offering on Wednesday, November 19th 2014. The company issued 3,500,000 shares at a price of $9.00 per share. MDB Capital Group, LLC acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Second Sight Medical Products investors own include Zynerba Pharmaceuticals (ZYNE), Adaptimmune Therapeutics (ADAP), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Canopy Growth (CGC) and Shopify (SHOP).

Company Calendar

Last Earnings
6/29/2020
Today
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:EYES
CIK
1266806
Employees
15
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.92 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-13.58%
Return on Assets
-13.02%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
22.15
Quick Ratio
22.15

Sales & Book Value

Annual Sales
$3.38 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.80 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
13,135,000
Free Float
6,935,000
Market Cap
$54.38 million
Optionable
Optionable
Beta
2.55

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:EYES) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners